The biofi lm of Candida albicans has been implicated as a source of bloodstream infections. Dispersal cells, as the fi nal biofi lm stage, are responsible for its spread. The aim of this study was to compare the susceptibility of biofi lm and dispersal cells vs. planktonic cells (overnight liquid culture) of C. albicans to caspofungin (CAS) and fl uconazole (FLU) when the drugs were added: i) at the beginning of the experiment; ii) after 1.5 h (adherence stage); iii) after 24 h (early mature biofi lm). The fi ndings were evaluated after 48 h (mature biofi lm) using the XTT reduction assay. Later administration of the drug increased biofi lm sessile minimal inhibitory concentration (SMIC 80 ) of both FLU and CAS from 1 μg mL -1 to over 64 μg mL -1 and from 0.125 μg mL -1 to over 16 μg mL -1 , respectively. Susceptibility of dispersal cells also decreased with time of administration. We also determined the expression of the Als1 and Als3 genes in 48-h sessile biofi lm and dispersal cells of C. albicans SC5314 and compared it to planktonic cells. The expression was normalised to the standard Act1 gene in every condition tested. Quantitative real-time PCR revealed a strong up-regulation of the Als1 gene in the dispersal cells but not in biofi lm and high expression of the Als3 gene in both biofi lm and dispersal cells. High expression of both Als1 and Als3 genes supports the hypothesis that dispersal cells pose a high-risk of infection.
Microbial biofi lm is a well-organised community of one or several microbial species (1) . Biofi lms have recently been associated with many infections, especially in patients using medical devices such as catheters, tracheal tubes, and joint implants (2, 3) . The yeasts of the genus Candida are the fourth most common cause of nosocomial bloodstream infections (4) . It has already been suggested that biofi lms formed on foreign bodies can be a serious source of such infections (2) . Therapy can be a problem because biofi lm is usually refractory to conventional therapy due to resistance or reduced uptake of antifungals through the extracellular matrix formed by mature biofi lm (5) (6) (7) . Recent in vitro and in vivo studies (8) (9) (10) (11) point to echinocandins caspofungin (CAS) and anidulafungin as effective agents against planktonic cells and biofi lms formed by C. albicans.
Biofi lm develops in four major stages: adherence stage, initial formation (pre-mature biofi lm), maturation (forming of extracellular matrix) and, cell dispersion (12, 13) . While the first three stages of biofilm formation have been studied in detail (5, 12, 13) , research on dispersal cells is still scarce. These cells are released from mature biofi lm into the blood stream and can cause infection and/or start a new biofi lm elsewhere. Dispersion can be triggered by changes in the concentration of carbon sources or growth conditions (14) , but little is known about gene regulation (15) . During the development of C. albicans biofilm, many specific genes are expressed. C. albicans adhesins Als1 and Als3 play an important role and are highly expressed in in vitro (16) as well as in vivo biofi lms (17, 18) . While the Als1 gene is expressed in the earlier stages of biofi lm formation (19) , the Als3 gene is mainly up-regulated in the mature biofi lm (11) . However, this is not a rule, as the expression of either gene can be signifi cantly affected by cultivation conditions (11, 20) .
The aim of this study was to see whether susceptibility of a biofi lm to antifungal drugs CAS and fl uconazole (FLC) is time-dependent and whether dispersal cells follow the susceptibility/resistance characteristics of biofi lm or of planktonic cells. In addition, we wanted to see whether the Als1 and Als3 genes are up-regulated in dispersal cells.
MATERIALS AND METHODS

Strain characterisation, preparation of the yeast suspension and MIC 80 determination
For this study, we used the standard strain C. albicans SC5314, as it is frequently used for wild-type control in systematic sequencing projects and for deriving laboratory strains. The original strain is a clinical isolate and it is virulent in mouse systemic infection (21 
Biofi lm formation and collection of non-adhered and dispersal cells
The biofi lm was prepared according to the protocol of Li et al. (23) . From each strain, 100 μL of cell suspension (10 6 cells mL
) prepared in YNB containing 0.9 % D-glucose was transferred into polystyrene, 96-well microplates (fl at bottom; Sarstedt, Germany) and incubated at 37 °C for 1.5 h to allow for the cells to attach. The medium with non-adhered cells was removed and the wells were gently washed twice with 150 μL of sterile PBS. For mature biofi lm to develop, 100 μL of fresh YNB medium with 0.9 % D-glucose was added and the plates were incubated at 37 °C. After 48 h, media containing dispersal cells were discarded and the wells were washed three times with 200 μL of sterile PBS. Biofi lm was estimated using the viability test with XTT [2,3-bis(2-methoxy-4-nitro-5-sulphenyl)-2H-tetrazolium-5-carboxanilide] sodium salt (Sigma-Aldrich, USA). The colorimetric reaction was determined using a microplate reader (OD 490 , MRX Microtiter plate absorbance reader, Dynex Technologies, USA) after 3 hour incubation at 37 °C in the dark. Three independent experiments were performed with each strain cultivated in three parallel wells. YNB medium containing no inoculum (no biofi lm) was used as control. The results were expressed as average ± standard deviation (SD).
Dispersal cells were prepared according to the biofi lm protocol with minor modifi cations. Briefl y, polystyrene Petri dishes (10 cm in diameter, Sarstedt, Germany) were inoculated with 10 7 cells mL -1 in 20 mL of YNB supplemented with 0.9 % D-glucose and cultivated at 37 °C for 90 min. After the adherence stage, media with non-adhered cells were removed and the collected cells were tested for MIC 80 as described above. The adhered cells were washed three times with 20 mL of sterile PBS. For biofi lm formation, 20 mL of fresh YNB medium was added and the plates were incubated at 37 °C for 24 h or 48 h. The dispersal cells from the supernatants of 24-hour and 48-hour sessile biofi lm were collected and tested for MIC 80 as described above. ) were added at three time points: 0 (the start of the experiment), 1.5 h (adherence stage), and 24 h (almost mature biofilm). All experiments were evaluated after 48 h (mature biofi lm) using the above-described XTT reduction assay. The results were expressed as sessile MIC 80 values (SMIC 80 ). Each assay was performed in triplicate and repeated in two independent experiments.
Biofi lm susceptibility testing
Quantitative Real-Time PCR (qRT-PCR)
C. albicans SC5314 planktonic cells (16-hour culture cultivated in an orbital shaker), 48-hour sessile biofi lm, and 48-hour dispersal cells, all cultivated in YNB containing 0.9 % D-glucose, were used for the isolation of total RNA (RNeasy Mini kit, Qiagen, USA). Three microgrammes of RNA were then treated with DNase I (TaKaRa Bio, Japan) and used for cDNA synthesis using the TaqMan Reverse Transcription kit (Applied Biosystems, USA Table 2 shows susceptibilities of the biofilms formed in the presence of FLC and CAS added at different time points. Both the standard strain and clinical isolate 21922/1 (with a weak biofi lm) remained susceptible to FLC when it was applied at the start of the experiment (time point 0) and after the adherence stage (time point 1.5 h). However, when added to early-mature biofi lm (time point 24 h), FLC did not inhibit it. Clinical isolate 16755/1 with a strong biofi lm did not respond to FLC at any time point, even at the concentration of 64 μg mL -1 . All strains were susceptible to CAS when applied at time point 0 (SMIC 80 was 0.125 μg mL -1 to 0.5 μg mL -1 ) and 1.5 h (SMIC 80 was 0.5 μg mL -1 ), but not after that.
We also tested the susceptibility to FLC and CAS of non-adhered cells collected at the adherence stage (time 1.5 h) and of dispersal cells taken from 24-hour and 48-hour biofi lm. Both non-adhered and dispersal cells (collected at either time point) remained susceptible to FLC (MIC 80 was in the range of 1.0 μg mL -1 to 4.0 μg mL -1 ), but susceptibility concentration of dispersal cells increased compared to the planktonic ones. The same was observed for CAS, with MIC 80 range between 0.5 μg mL -1 and 1.0 μg mL -1 . As the susceptibility of the dispersal cells was lower than of the planktonic cells, and these cells can spread in the human body through blood and can form a new biofi lm, it was interesting to learn more about their adherence properties. To do that we compared the expression of C. albicans SC5314 Als1 and Als3 genes in dispersal cells and sessile biofi lm with the expression of those genes in planktonic cells cultured overnight. The expression of the tested genes was normalised to the standard Act1 gene under every set of testing conditions. Because of possible changes in Act1 expression during the morphogenesis of C. albicans in biofi lm, data were also normalised to the Tef1 gene (data not shown). However, the results were very similar regardless of the housekeeping gene used. The qRT-PCR revealed up-regulation of both Als1 and Als3 genes in biofi lm and dispersal cells in comparison with planktonic ones (Figure 1) . However, the Als1 gene was markedly up-regulated in dispersal cells, but not in sessile biofilm, while the Als3 gene was signifi cantly up-regulated in both (p<0.05).
DISCUSSION
Biofi lm-associated infections are a general problem in immunocompromised or critically ill patients with foreign bodies (2, 26) . The yeast C. albicans is the most common source of nosocomial bloodstream infections (4), mostly associated with the use of medical devices. FLC is often used to treat acute or chronic vaginal candidiasis and fungal infections in hospitalised patients or to prevent fungal infections in AIDS patients (27) (28) (29) . However, the number of azoleresistant, mainly non-C. albicans isolates has increased in hospital care (30) , limiting its application. Moreover, in critically ill patients receiving presumptive therapy, new azoles, amphotericin B, or echinocandins are used instead of FLC to avoid complications associated with fungal infections, biofi lms in particular.
Our previous in vitro study (11) confi rmed the effi ciency of anidulafungin and CAS against sessile biofi lm when added at the early stage of formation. Our present study has confirmed that biofilm susceptibility changes in a time-dependent manner. Early-formed (24-hour) biofi lm proved to be resistant to either FLC or CAS, regardless of the strain tested. ). In contrast to Uppulari et al. (31) , who found the same susceptibility profi le to CAS for dispersal and for planktonic cells, our data showed differences in susceptibility; later CAS administration resulted in lower effi cacy, but CAS concentrations were still within its therapeutic dose.
Dispersal cells have phenotypic properties that can signifi cantly contribute to virulence (14) . To date, only a few genes participating in dispersion have been profi led (15, 32) . Our study has provided new data on the expression of two important genes encoding for adhesins Als1 and Als3, completing the earlier fi ndings (11, 16, 19) . In agreement with them the Als1 gene was signifi cantly up-regulated in the early biofi lm stage, and the Als3 gene in the mature one. However, up-regulation of the Als1 gene in dispersal cells collected from 48-hour biofi lm suggests that cell dispersion could be not only the last stage of biofi lm development but also the stage where a new one begins. Moreover, the high expression of the Als3 gene underlines high adherence capacity of dispersal cells and confi rms that these cells differ from planktonic not only in phenotype, but also in the regulation of genes important for virulence.
In summary, the effects of both FLC and CAS on biofi lm proved to depend on the application time; later administration resulted in an increase in SMIC 80 in biofi lm and in MIC 80 in dispersal cells. CAS proved to be more effective than FLC. In contrast to regulation in mature biofi lm, both the Als1 and Als3 genes were signifi cantly up-regulated in dispersal cells collected from the 48-hour mature biofi lm. Our fi ndings point to high virulence of dispersal cells and them as a highrisk source of infection.
